1. Home
  2. RELL vs OTLK Comparison

RELL vs OTLK Comparison

Compare RELL & OTLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Richardson Electronics Ltd.

RELL

Richardson Electronics Ltd.

N/A

Current Price

$20.74

Market Cap

248.1M

Sector

Technology

ML Signal

N/A

Logo Outlook Therapeutics Inc.

OTLK

Outlook Therapeutics Inc.

N/A

Current Price

$0.60

Market Cap

249.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RELL
OTLK
Founded
1947
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
248.1M
249.6M
IPO Year
2004
2016

Fundamental Metrics

Financial Performance
Metric
RELL
OTLK
Price
$20.74
$0.60
Analyst Decision
Buy
Analyst Count
0
4
Target Price
★ $20.50
$5.03
AVG Volume (30 Days)
184.6K
★ 3.4M
Earning Date
10-07-2026
08-14-2026
Dividend Yield
★ 1.20%
N/A
EPS Growth
N/A
★ 55.91
EPS
★ N/A
N/A
Revenue
★ $228,564,000.00
$8,146,123.00
Revenue This Year
$9.68
N/A
Revenue Next Year
$6.86
$6,355.64
P/E Ratio
$230.96
★ N/A
Revenue Growth
★ 9.41
N/A
52 Week Low
$9.37
$0.16
52 Week High
$23.15
$2.54

Technical Indicators

Market Signals
Indicator
RELL
OTLK
Relative Strength Index (RSI) 70.08 40.15
Support Level $15.41 $0.60
Resistance Level $21.74 $0.70
Average True Range (ATR) 0.87 0.04
MACD 0.38 0.00
Stochastic Oscillator 80.21 37.58

Price Performance

Historical Comparison
RELL
OTLK

About RELL Richardson Electronics Ltd.

Richardson Electronics Ltd is a world-wide manufacturer of engineered solutions, green energy products, power grid and microwave tubes, and related consumables; power conversion and RF and microwave components including green energy solutions; tubes for diagnostic imaging equipment; and customized display solutions. It serve customers in alternative energy, healthcare, aviation, broadcast, communications, industrial, marine, medical, military, scientific, and semiconductor markets. Its products and services include design-in support, systems integration, prototype design and manufacturing, testing, logistics, etc. Its segments are Power and Microwave Technologies (PMT), Green Energy Solutions (GES), and Canvys. Majority of Sales is from PMT. Majority of sales is from North America.

About OTLK Outlook Therapeutics Inc.

Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA, which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.

Share on Social Networks: